Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1540-1545

  Rampy, Mark A ^b   Brown, Raya S ^b   Pinchuk, Anatoly N ^b   Weichert, Jamey P ^b   Skinner, R W Scott ^b   Fisher, Susan J ^b   Wahl, Richard L ^b   Gross, Milton D ^b   Ethier, Stephen P ^b   Counsell, Raymond E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

breast cancer; radioiodinated phospholipid ethers; tumor localization

Indexed keywords

12 (3 IODOPHENYL)DODECYLPHOSPHOCHOLINE I 125; DIAGNOSTIC AGENT; IODINE 125; NM 324; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GRAFT; CANCER MODEL; DIAGNOSTIC VALUE; DRUG DISPOSITION; DRUG DISTRIBUTION; FEMALE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; SCINTILLATION CAMERA; TUMOR LOCALIZATION; WHOLE BODY SCINTISCANNING;

ANIMALS; FEMALE; HUMANS; IODINE RADIOISOTOPES; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; PHOSPHOLIPID ETHERS; RATS; RATS, INBRED LEW; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 10144239662     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Goldenberg DM, Larson SM. Radioimmunodetection in cancer identification. J Nucl Med 1992;33:803-814.
2. Thor AD, Edgerton SM. Monoclonal antibodies reactive with human breast and ovarian carcinoma: in vivo applications. Semin Nucl Med 1989;19:295-308.
3. DeNardo SJ, O'Grady LF, Macey DJ, et al. Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategy. Nucl Med Biol 1991;18:621-631.
4. 2) - part II. Preliminary results in patients with breast carcinoma. Nucl Med Biol 1992;19:263-267.
5. Mintun MA, Welch MJ, Siegel BA, et al. Breast cancer: PET imaging of estrogen receptors. Radiology 1988;169:45-48.
6. Furr BJA, Jordan VC. The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 1984;25:127-132.
7. Pomper MG, Pinney KG, Carlson KE, et al. Target tissue uptake selectivity of three fluorine-substituted progestins: potential imaging agents for receptor positive breast tumors. Nucl Med Biol 1990;17:309-319.
8. Wahl RL, Cody R, Hutchins G, Kuhl D. 2-Deoxy-2-F-18-fluoro-glucose (FDG) PET assessment of the early metabolic response of breast carcinoma to chemochronotherapy [Abstract]. Proc Am Assoc Cancer Res 1990;31:A1088.
9. Cody R, Hutchins G, Wahl RL. PET imaging of primary and metastatic breast cancer with 2-fluoro-18F-2-deoxy-d-glucose (FDG) [Abstract]. Proc Am Soc Clin Oncol 1990;9:A189.
10. 18F]-2-fluoro-2-deoxy-D-glucose (FDG) scintigraphy of normal and tumor-bearing rats. Res Exp Med (Berl) 1986;186(4):249-258.
11. Snyder F, Wood R. Alkyl and alk-1-enyl ethers of glycerol in lipids from normal and neoplastic human tissues. Cancer Res 1969;29:251-257.
12. Snyder F, Blank ML, Morris HP. Occurrence and nature of O-alkyl and O-alk-1-enyl moieties of glycerol in lipids of Morris transplanted hepatomas and normal rat livers. Biochim Biophys Acta 1969;176:502-510.
13. Soodsma JF, Piantadosi C, Snyder F. The biocleavage of alkyl glyceryl ethers in Morris hepatomas and other transplantable neoplasms. Cancer Res 1970;30:309-311.
14. Meyer KL, Schwendner SW, Counsell RE. Potential tumor or organ imaging agents 30. Radioiodinated phospholipid ethers. J Med Chem 1989;32:2142-2147.
15. Counsell RE, Schwendner SW, Meyer KL, Haradahira T, Gross MD. Tumor visualization with a radioiodinated phospholipid ether. J Nucl Med 1990;31:332-336.
16. Plotzke KP, Haradahira T, Stancato L, et al. Selective localization of radioiodinated alkylphosphocholine derivatives in tumors. Nucl Med Biol 1992;19:775-782.
17. Plotzke KP, Fisher SJ, Wahl RL, Olken NM, Skinner S, Gross MD, Counsell RE. Selective localization of a radioiodinated phospholipid ether analog in human tumor xenografts. J Nucl Med 1993;34:787-792.
18. Ethier SP. Primary culture and serial passage of normal and carcinogen-treated rat mammary epithelial cells in vitro. J Natl Cancer Inst 1985;74:1307-1318.
19. Ethier SP, Cundiff KC. Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat mammary carcinoma cells. Cancer Res 1987;47:5316-5322.
20. Ethier SP, Moorthy R. Multiple growth factor independence in rat mammary carcinoma cells. Breast Cancer Res Treat 1991;18:73-81.
21. Simpson RU, Arnold AJ. Calcium antagonizes 1,25-dihydroxyvitamin D3 inhibition of breast cancer cell proliferation. Endocrinology 1986;119:2284-2289.
22. Simpson RU, Taylor JT. Regulation of cancer cell proliferation by calcium antagonists. Exper Oncol (Life Sci Adv) 1988;7:81-89.
23. Taylor JT, Simpson RU. Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse. Cancer Res 1992;52:2413-2418.
24. Weichert JP, VanDort ME, Groziak MP, Counsell RE. Radioiodination via isotope exchange in pivalic acid. Appl Radiat Isot 1986;37:907-913.
25. Folch J, Lees M, Sloane-Stanley FG. A simple method for the isolation of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
26. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med 1995;36:1854-1861.
27. Brown RS, Fisher SJ, Wahl RL. Autoradiographic evaluation of the intratumoral distribution of 2-deoxy-D-glucose and monoclonal antibodies in xenografts of human ovarian adenocarcinoma. J Nucl Med 1993;34:75-82.
28. Plotzke KP, Rampy MA, Meyer K, et al. Biodistribution, metabolism, and excretion of radioiodinated phospholipid ether analogs in tumor-bearing rats. J Nucl Biol Med 1993;37:264-272.